Consortium management of triple therapy cost pressures for HIV/AIDS in the North East of England

Abstract

Reviews NHS policy for the introduction of new technology and drug developments into the NHS with reference to HIV therapy. Also reviews current policy issues related to NHS rationing and priority setting with reference to commissioning services for HIV infection and AIDS. Confirms the destabilisation of HIV contracts in the North East of England caused by the introduction of double therapy in 1996 and triple therapy in 1997 in relation to the above policy areas. Also reviews purchaser and provider contracting following the introduction of triple therapy for HIV infection. Finally, concludes by reviewing local policy and management arrangements and recommendations for change.

Citation

Tregoning, D. and Craven, B.M. (2001), "Consortium management of triple therapy cost pressures for HIV/AIDS in the North East of England", British Journal of Clinical Governance, Vol. 6 No. 4, pp. 233-240. https://doi.org/10.1108/EUM0000000006047